Abuse of cocaine has been linked to the development of psychiatric disorders and seizures. These effects are probably not simply due to overdose, but instead may be related to the repetitive abuse of the drug. Repetitive, intermittent administration of cocaine produces progressive changes in behavior and/or augmentation of the acute behavioral effects of cocaine in several species including rats and monkeys. An augmented response to cocaine can be elicited at least a month after the last cocaine injection and may even be permanent. Thus, this long-lasting alteration in sensitivity to cocaine implies changes in neurochemical and neurophysiological substrates subserving these behaviors. There is reason to believe that these changes may be important in the development of psychiatric symptomatology associated with chronic cocaine abuse and many investigators believe that sensitization to psychomotor stimulants such as cocaine has relevance as a model for the development of endogenous psychiatric diseases such as anxiety/panic disorder, depression and paranoid schizophrenia. It may also be relevant to cocaine """"""""addiction"""""""" and """"""""craving"""""""" which undoubtedly play a role in its pattern of abuse. We propose to test the hypothesis that behavioral sensitization in the rat is mediated by alterations in dopaminergic neurotransmission or by neuronal influences directly involved in its regulation. We also propose that these alterations will be reflected in systems modulated by dopaminergic output. We will use a combination of in vivo and in vitro techniques to answer questions concerning dopamine synthesis, metabolism, release, and reuptake in three primary projection fields: 1) striatum, 2) nucleus accumbens, and 3) prefrontal cortex. These studies will also include the cell body areas for the nigrostriatal and mesolimbic/mesocortical systems. These studies will also determine the effects of cocaine sensitization on systems such as the striatal cholinergic and nigral GABAergic interneurons which are modified by dopaminergic activity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA005159-03
Application #
3211283
Study Section
Special Emphasis Panel (SRCD (02))
Project Start
1989-05-01
Project End
1992-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Gifford, A N; Bergmann, J S; Johnson, K M (1993) GBR 12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices. Drug Alcohol Depend 32:65-71
Gifford, A N; Johnson, K M (1993) A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors. Eur J Pharmacol 237:169-75
Johnson, K M; Bergmann, J S; Kozikowski, A P (1992) Cocaine and dopamine differentially protect [3H]mazindol binding sites from alkylation by N-ethylmaleimide. Eur J Pharmacol 227:411-5
Gifford, A N; Johnson, K M (1992) Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine. J Pharmacol Exp Ther 263:757-61
Woolverton, W L; Johnson, K M (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200
Gifford, A N; Johnson, K M (1992) Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum. Pharmacol Biochem Behav 41:841-6
Yi, S J; Gifford, A N; Johnson, K M (1991) Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes. Eur J Pharmacol 199:185-9
Yi, S J; Johnson, K M (1990) Effects of acute and chronic administration of cocaine on striatal uptake, compartmentalization and release of [3H]dopamine. Neuropharmacology 29:475-86
Yi, S J; Johnson, K M (1990) Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors. Pharmacol Biochem Behav 36:457-61